Abcam Ltd - Company Profile
Powered by 
All the sales intelligence you need on Abcam Ltd in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Abcam Ltd fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Abcam Ltd.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Related keylists
Abcam Ltd (Abcam) a subsidiary of Danaher Corp, is a supplier of life science research tools for analysis of living cells at the molecular level to understand a wide range of disease conditions. The company develops and markets antibodies and other related products. Its product portfolio includes primary antibodies, secondary antibodies, immunoassay kits and reagents, cell and tissue imaging tools, cellular and biochemical assays, proteomics tools, proteins and peptides, activators, agonists, antagonists and inhibitors, lysates, and multiplex miRNA assay. Abcam’s products serve life science researchers to identify proteins for life sciences and veterinary sciences. The company distributes its products in the Americas, Europe, Asia-Pacific and other countries. Abcam is headquartered in Cambridge, Cambridgeshire, the UK.
Headquarters
United Kingdom
Address
Cambridge Biomedical Campus, Hills Road, Discovery Drive, Cambridgeshire, CB20AX
Website
www.abcam.com
Telephone
44 1223 696000
No of Employees
635
Industry
Medical Equipment
Revenue (2024)
$301.6M
Abcam Ltd premium industry data and analytics
Products and Services
| Products | Services | Brands |
|---|---|---|
| Antibodies | Distribution | RabMab |
| Research-Grade Antibodies | Custom Conjugation Services | |
| In Vitro Diagnostic (IVD) Antibodies | ||
| XYZ | ||
| XYZ | ||
| XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2025 | Contracts/Agreements | In October, the company partnered with Molecular Instruments to integrate MI’s HCR HiFi Encoder with Abcam’s RabMAb and mouse antibodies for enhanced multiplex immunofluorescence and co-detection. |
| 2023 | Ownership Changes | In December, the company was acquired by Danaher Corp, a global life sciences and diagnostics provider for US$5.7 billion. |
| 2023 | Contracts/Agreements | In April, the company came into agreement for primary antibody validation for use on Comet. |
Competitor Comparison
| Key Parameters | Abcam Ltd | Siemens Healthineers AG | bioMerieux SA | Illumina Inc | Beckman Coulter Inc |
|---|---|---|---|---|---|
| Headquarters | United Kingdom | Germany | France | United States of America | United States of America |
| City | Cambridge | Forchheim | Craponne | San Diego | Brea |
| State/Province | Cambridgeshire | Bayern | Rhone Alpes | California | California |
| No. of Employees | 635 | 72,000 | 15,226 | 8,600 | 11,000 |
| Entity Type | Private | Public | Public | Public | Private |
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Markus Lusser | Director; President | Executive Board | 2024 | 58 |
| Knud Muller | Chief Financial Officer | Senior Management | - | - |
| Emma Alejandra Solache Diaz | Senior Vice President - Research & Development | Senior Management | 2025 | 57 |
| Nadia Altomare | Vice President - Commercial Operations | Senior Management | - | - |
| Ahmed Hasan | Chief Digital Officer | Senior Management | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer